Carvedilol Tablet, Film Coated
Product Images NDC 63629-4060

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 63629-4060). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

B1fa8af3 9789 45d2 8b77 A53935c52b49 01

Chemical structure diagram of Carvedilol, depicting its molecular framework with labeled chemical groups and bond configurations.*

FDA Label Image

B1fa8af3 9789 45d2 8b77 A53935c52b49 02

A line chart comparing mortality percentage over 21 months between Carvedilol and placebo groups. The y-axis represents % mortality from 0 to 30%, and the x-axis represents time in months from 0 to 21. Two curves show lower mortality in the Carvedilol group than placebo, with a p-value of 0.0014 indicated on the graph.*

FDA Label Image

B1fa8af3 9789 45d2 8b77 A53935c52b49 03

A forest plot chart showing hazard ratios for various patient subgroups including gender, age, race, diabetic status, ischemic status, heart rate, systolic blood pressure, and spironolactone use. The data points are plotted relative to a hazard ratio of 1.0, with horizontal lines indicating confidence intervals for each subgroup, concluding with an overall hazard ratio for all patients.*

FDA Label Image

B1fa8af3 9789 45d2 8b77 A53935c52b49 04

A line graph showing percent mortality over 24 months comparing Carvedilol to Placebo. The x-axis represents time in months, and the y-axis shows percent mortality. The graph depicts lower mortality for Carvedilol compared to Placebo, with a statistical significance noted by P = 0.03.*

FDA Label Image

B1fa8af3 9789 45d2 8b77 A53935c52b49 05

A forest plot chart displaying hazard ratios with confidence intervals for various patient subgroups related to heart conditions, such as age, gender, prior and current congestive heart failure (CHF), use of diuretics, angina status, hypertension, diabetes, heart rate, systolic blood pressure (SBP), and others. The chart visually compares the hazard ratios across these subgroups using horizontal lines and dots.*

FDA Label Image

Label Image (Lbl636294060)

Label for Carvedilol 3.125 mg film-coated tablets, an oral prescription drug by Bryant Ranch Prepack. The label states it is packaged by Bryant Ranch Prepack in Burbank, CA, and compares the product to Coreg 3.125 mg tablets by Cadila Healthcare Limited. It includes storage instructions to keep at 20°-25°C (68°-77°F) and has an NDC number 63629-4060-1. The label also displays a barcode and indicates a quantity of 30 tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.